REATA PHARMACEUTICALS INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2015 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Reata Pharmaceuticals Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2015 to Q4 2022.
  • Reata Pharmaceuticals Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $424M, a 14.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $424M +$54.8M +14.9% Dec 31, 2022 10-K 2023-02-24
Q4 2021 $369M +$68.3M +22.7% Dec 31, 2021 10-K 2023-02-24
Q4 2020 $301M +$74.6M +33% Dec 31, 2020 10-K 2022-02-28
Q4 2019 $226M +$98.5M +77.1% Dec 31, 2019 10-K 2021-03-01
Q4 2018 $128M +$27.2M +27% Dec 31, 2018 10-K 2020-02-19
Q4 2017 $101M -$22.8M -18.5% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $123M +$1.69M +1.39% Dec 31, 2016 10-K 2018-03-02
Q4 2015 $122M Dec 31, 2015 10-K 2017-03-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.